Comparison

Neodocs vs Kribado

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Neodocs

Monitor your kidney health instantly from home with lab-quality results in 30 seconds. Detect early signs of Chronic Kidney Disease (CKD) with uACR and eGFR measurements. Generate professional reports and receive expert guidance.

Highlights
  • Instant uACR testing (30 seconds)
  • Latest eGFR calculator (CKD-EPI 2021)
  • Clinically validated accuracy (96% sensitivity)
  • Professional, lab-style reports
  • Free expert guidance on results
  • Home-based kidney health monitoring
Features
Read full description

Neodocs - Your Personal Kidney Health Monitor Transform the way you monitor your kidney health with our innovative app that delivers lab-quality results in just 30 seconds, all from the comfort of your home. Why Monitor uACR and eGFR? Chronic Kidney Disease (CKD) is a silent condition where symptoms typically don't appear until 90% of kidney damage has occurred, often leaving patients at the verge of dialysis. People with diabetes or high blood pressure are at particularly high risk of developing CKD, making regular monitoring of kidney parameters crucial. Two key measurements help protect your kidney health: •⁠ ⁠uACR (Urine Albumin-to-Creatinine Ratio): This vital marker helps in early detection of CKD, often identifying problems years before symptoms appear •⁠ ⁠eGFR (estimated Glomerular Filtration Rate): This measures your kidneys' filtering capacity, helping you understand how well your kidneys are functioning Key Features: •⁠ ⁠Rapid Testing: Get your uACR levels in 30 seconds, enabling early detection of CKD when intervention is most effective •⁠ ⁠Latest eGFR Calculator: Featuring the most current CKD-EPI 2021 equation for accurate kidney function assessment •⁠ ⁠Clinically Validated: 96% sensitivity and 99% specificity ensuring reliable results you can trust •⁠ ⁠Professional Reports: Generate comprehensive, lab-style reports to share with your healthcare providers •⁠ ⁠Free Expert Guidance: Access professional consultation to understand your results and next steps Why Choose Neodocs? Skip the hassle of traveling to labs and waiting hours for results. Our app puts professional-grade kidney health monitoring in your pocket. Whether you're managing existing kidney conditions or taking preventive measures against Chronic Kidney Disease (CKD), Neodocs provides the tools you need to stay informed about your health. Perfect For: •⁠ ⁠People wanting to proactively monitor their kidney health •⁠ ⁠Individuals at risk of developing CKD •⁠ ⁠Anyone looking to avoid complications that could lead to dialysis •⁠ ⁠Health-conscious individuals seeking convenient health monitoring solutions Our Commitment: At Neodocs, we believe in measuring what matters. Our mission is to empower you with accurate, timely information about your kidney health, helping you maintain a healthy lifestyle through regular monitoring and early detection of potential issues. Download Neodocs today and take control of your kidney health with confidence! Note: Always consult with healthcare professionals for medical advice and treatment decisions.

About

Kribado

Features
Read full description

The Kribado is the next generation risk stratification and behaviour setting device for Healthcare Practitioners (HCP) and Healthcare companies. A non-invasive screening protocol that instantly provides a risk score for a patient in the waiting room, making it possible to triage these patients to the relevant areas/procedures by early identification of risk. It is designed to eliminate data collection errors by structuring each screen so that it is easy to use with consistent data. The Kribado will assist physicians in treating patients by implementing a pre-admission risk strat. Kribado consists of a small touch-screen connected to a embeded printer, and operates using AI and risk scoring algorithms trained on perfect human data. The end result is that it helps alert the healthcare professionals to potential behavioral risk factors of each patient in waiting areas. It also gives each company an accurate overview of their surveys, phase IV studies and in-clinic camps.

Screenshots

Neodocs4 screens
Kribado4 screens

Verdict

The call

Neodocs and Kribado are too close to call on the numbers: across 6 compared parameters — price, update cadence, ads and in-app purchases among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

Neodocs ships an update weekly, Kribado every 2 weeks. The most recent releases landed on October 24, 2026 and October 27, 2026 respectively.

ScorecardNo meaningful differences
Neodocs versus Kribado: the parameters behind the verdict, then further details
ParameterNeodocsKribado
PriceFreeFree
Rating5.0 (5 ratings) — better—
Positive reviews86.7% of reviews—
Number of ratings5 — better—
Update frequencyWeekly — betterEvery 2 weeks
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS15 — better15.5
Further details — not scored
Size149 MB88 MB
Age rating12+12+
DeveloperNeodocs Healthcare Private LimitedIndigital Technologies LLP

In-app purchases

None

Neodocs

No in-app purchases

None

Kribado

No in-app purchases

Questions

Is Neodocs free?
Neodocs is free to download, with no in-app purchases.
Is Kribado free?
Kribado is free to download, with no in-app purchases.
Do Neodocs or Kribado have ads?
Neither Neodocs nor Kribado shows ads.
Which is updated more often, Neodocs or Kribado?
Neodocs ships an update weekly, and Kribado every 2 weeks. Most recently, Neodocs was updated on October 24, 2026 and Kribado on October 27, 2026.

Other comparisons